EN English ENEnglish (UK) ENEnglish (IN) DEDeutsch FRFrançais ESEspañol ITItaliano PLPolski SVSvenska TRTürkçe RUРусский PTPortuguês IDBahasa Indonesia MSBahasa Melayu THภาษาไทย VITiếng Việt JA日本語 KO한국어 ZH简体中文 ZH繁體中文 ARالعربية
TradingView
Ticker Trading Ideas Educational Ideas Scripts People
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Sign Out Go PRO Go PRO 30-day Free Trial Go PRO Early
US Stocks Healthcare Medical Equipment, Supplies & Distribution

BIOCEPT INC NASDAQ:​BIOC

 
     
 
     
Prev
 
Open
 
Volume
 
1 Day Range
  -  
EPS
 
Mkt Cap
 
PE
 
Div Yield
 
Overview Ideas Technicals
Popular Today
Popular Today
Popular All Time
Newest
Charts and Videos
Charts and Videos
Charts
Videos
Full-Featured Chart

BIOC Stock Chart

Technicals

Profile

Financials

Price History
Average Volume (10 day) ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Valuation
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Price/Book Ratio, FY ---
Price/Sales Ratio, FY ---
Dividends
Dividends Paid, FY ---
Dividends per Share, FQ ---
Expected Annual Dividends ---
Dividends Yield ---
Margins
Net Margin, TTM ---
Gross Margin, TTM ---
Operating Margin, TTM ---
Pretax Margin, TTM ---
Balance Sheet
Current Ratio, FQ ---
Debt to Equity, FQ ---
Net Debt, FQ ---
Quick Ratio, FQ ---
Total Assets, FQ ---
Total Debt, FQ ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
EBITDA, TTM ---
Gross Profit, FY ---
Last Annual EPS ---
Last Annual Revenue, FY ---
Net Income, FY ---
Total Revenue, FY ---
Free Cash Flow, TTM ---
Operating Metrics
Return on Assets, TTM ---
Return on Equity, TTM ---
Return on Invested Capital, TTM ---
Revenue per Employee, TTM ---

News

King-of-WallStreet King-of-WallStreet BIOC, 240, Long ,
BIOC: $BIOC Trade Plan
107 0 0
BIOC, 240 Long
$BIOC Trade Plan

Private Guidance

OvachoInvestments OvachoInvestments BIOC, D,
BIOC: Updated Chart 4/7/18
50 0 3
BIOC, D
Updated Chart 4/7/18

(BIOC)

OvachoInvestments OvachoInvestments BIOC, D,
BIOC: BIOC Updated Chart
38 0 3
BIOC, D
BIOC Updated Chart

Read Chart Descriptions!

rt3eod rt3eod BIOC, 1D,
BIOC: What I like about #BIOC as an overnight swing.
83 0 1
BIOC, 1D
What I like about #BIOC as an overnight swing.

What I like about BIOC: 1. Higher lows on the daily 2. RSI crossed above the 50 3. MACD still bullish 4. Range to 50ma within reach. 5. Break above 50ma could fill gap to .49 6. MA's in alignment. 7. Showed up on EOD scan - 87% chance of running tomorrow.

silenthazee silenthazee BIOC, D, Long ,
BIOC: will this babe run?
51 1 4
BIOC, D Long
will this babe run?

Technical Analysis

redaidriss redaidriss BIOC, 60, Long ,
BIOC: BIOC , Long ?
110 1 5
BIOC, 60 Long
BIOC , Long ?

The stock is a big % Gainer , it will be in the watchlist of many traders this week and might be going up after its apocalypse The price now is in a rang between 1.80 and 1.40 If it will break The 1.80 , we have a great probability to go long to the 3.37 ( Last Big top ) forming perhaps a double top for another colapse ( Or not ) If it will break the 1.40 , ...

Edwardehz Edwardehz BIOC, D,
BIOC: price below pivot point, resistance broken
50 0 3
BIOC, D
price below pivot point, resistance broken

Tech Analysis

Edwardehz Edwardehz BIOC, D,
BIOC: support became resistance
38 0 3
BIOC, D
support became resistance

Tech Analysis

Edwardehz Edwardehz BIOC, 60, Long ,
BIOC: Waiting for a break above the channel
25 0 1
BIOC, 60 Long
Waiting for a break above the channel

Tech Analysis

AntonioNaVi AntonioNaVi BIOC, D, Long ,
BIOC: Great Revival pattern under 1
70 0 4
BIOC, D Long
Great Revival pattern under 1

Long > 1 Stop - .95 Target - 1.15

mchedester mchedester BIOC, D, Long ,
BIOC: Biocept - Buy the negativity. The revenue doesn't mind.
39 1 0
BIOC, D Long
Biocept - Buy the negativity. The revenue doesn't mind.

Biocept has the best-in-breed liquid biopsy testing in the Immuno-Oncology space. Market cap is 70 million, but it's going to be several billion in a few years if they don't get bought out first. Revenue in the second quarter ended 6/30/2016 increased 8 fold to 663,000 from 77,000 last year. This revenue only included half of June for their commerical launch of ...

trademan1 trademan1 BIOC, D, Long ,
BIOC: BIOC Measured Move Resuming
132 0 1
BIOC, D Long
BIOC Measured Move Resuming

The pennant consolidation is about over, it is ready to break out and make the next leg of its upward journey starting out with a measured move. Since it is so close to the apex of the pennant with a doji, anyone short should consider covering immediately.

Community & Tools
House Rules Moderators People Chat Stock Screener Forex Screener Crypto Screener Economic Calendar AppStore
For Business
Website & Broker Solutions Widgets Charting Library Trading Terminal Brokerage Integration Advertising Referral Program Content Streams & RSS
Support
Contact Support Status Page Blog Feature Request Help & Wiki FAQ Contacts
About
How It Works Features Pricing Press Terms of Use Risk Warning Privacy Policy Cookies Policy
© 2018 TradingView
Stock Charts & Forex Charts
Made with
From the creators of MultiCharts
Select market data provided by ICE Data services
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out
Go PRO Go PRO 30-day Free Trial Go PRO Early
Browse
Video